Indeed, there is evidence that, in IBD, Smad7 undergoes acetylation, a dynamic post-translational modification that prevents proteasome-mediated ubiquitination-driven degradation (Monteleone et al., 2005). The gene discussed is SMAD7; the disease is inflammatory bowel disease.